Clinical Trials on Inherited Retinal Degeneration
Total 17037 results
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, United Kingdom
-
National Eye Institute (NEI)CompletedAge-Related Macular DegenerationUnited States
-
Unity Health TorontoTerminatedAge Related Macular DegenerationCanada
-
Maturi, Raj K., M.D., P.C.CompletedAge-Related Macular DegenerationUnited States
-
Ohr Pharmaceutical Inc.WithdrawnAge-Related Macular DegenerationUnited States
-
David M. Brown, M.D.Regeneron PharmaceuticalsCompletedAge Related Macular DegenerationUnited States
-
Association for Innovation and Biomedical Research...CompletedAge Related Macular DegenerationPortugal
-
Retina Center, MinnesotaGenentech, Inc.CompletedAge-Related Macular DegenerationUnited States
-
Sequenom, Inc.Center for Eye Research and EducationCompletedAge Related Macular DegenerationUnited States
-
Johann Wolfgang Goethe University HospitalCompletedAge-Related Macular DegenerationGermany
-
Forsight Vision4WithdrawnAge-Related Macular DegenerationIsrael
-
Progen PharmaceuticalsCompletedAge Related Macular DegenerationUnited States, Mexico, Russian Federation
-
University of JenaCompleted
-
Illinois Retina AssociatesNovartis PharmaceuticalsCompletedAge-Related Macular DegenerationUnited States
-
CoMentisCompletedAge-Related Macular Degeneration
-
Notal Vision Ltd.CompletedAge-Related Macular DegenerationUnited States
-
Rudolf Foundation ClinicUnknownAge-Related Macular DegenerationAustria
-
Maastricht University Medical CenterCognis Deutschland GmbH & Co. KGCompletedAge-Related Macular DegenerationNetherlands, United Kingdom
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Weill Medical College of Cornell UniversityCompletedAge Related Macular DegenerationUnited States
-
Rudolf Foundation ClinicCompletedAge Related Macular Degeneration
-
Centre Hospitalier Intercommunal CreteilRecruitingMacular DegenerationFrance
-
IVERIC bio, Inc.Terminated
-
University of WaterlooThe Hong Kong Polytechnic UniversityCompleted
-
Xbrane Biopharma ABStada Arzneimittel AGCompletedMacular DegenerationIsrael, Spain, Hungary, United States, Slovakia, Lithuania, Bulgaria, Czechia, Estonia, India, Latvia, Poland, Romania, Russian Federation, Ukraine
-
Genentech, Inc.Completed
-
AllerganCompletedMacular DegenerationUnited States, Japan, United Kingdom, Italy, Taiwan, Australia, Canada, Hungary, Poland, Russian Federation, Netherlands, Brazil, Denmark, Peru, South Africa, Turkey
-
AllerganCompletedMacular DegenerationSpain, United States, Korea, Republic of, Israel, Singapore, Argentina, Germany, France, Czechia, Austria, Philippines, Switzerland, Chile, Colombia, Hong Kong, Latvia, New Zealand
-
Lahey ClinicCompletedMacular DegenerationUnited States
-
VA Office of Research and DevelopmentCompletedMacular DegenerationUnited States
-
AllerganCompleted
-
AllerganCompletedMacular DegenerationUnited States
-
Allegro Ophthalmics, LLCCompletedMacular DegenerationMexico
-
GlaxoSmithKlineTerminatedMacular DegenerationUnited States, France, Germany
-
National Eye Institute (NEI)CompletedMacular DegenerationUnited States
-
Hoffmann-La RocheCompletedMacular DegenerationUnited States, United Kingdom
-
AllerganCompletedMacular DegenerationUnited States
-
University of BernUniversity Hospital, Zürich; ISS AGCompletedMacular DegenerationSwitzerland
-
Steven R. SanisloGenentech, Inc.; California Pacific Medical Center; Pacific Eye AssociatesCompleted
-
University of ZurichCompletedMacular DegenerationSwitzerland
-
Regeneron PharmaceuticalsBayerCompletedMacular DegenerationUnited States
-
Germans Trias i Pujol HospitalCompleted
-
OPKO Health, Inc.TerminatedMacular DegenerationUnited States, Canada
-
Genentech, Inc.Completed
-
Regeneron PharmaceuticalsBayerCompletedMacular DegenerationUnited States, Canada
-
Alcon ResearchCompletedMacular DegenerationUnited States
-
Institute of Vision, BrasilUnknownMacular DegenerationBrazil
-
Oregon Health and Science UniversityCompletedMacular DegenerationUnited States
-
Jerini OphthalmicCompletedA Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMDMacular DegenerationUnited States